Document is current
Any future updates will be listed below
-
Authors
Thaweethai, Tanayott https://orcid.org/0000-0003-0613-4176
Donohue, Sarah E. https://orcid.org/0000-0002-2790-2552
Martin, Jeffrey N. https://orcid.org/0000-0002-9773-3256
Hornig, Mady https://orcid.org/0000-0001-7572-3092
Mosier, Jarrod M.
Shinnick, Daniel J.
Ashktorab, Hassan
Atieh, Ornina
Blomkalns, Andra https://orcid.org/0000-0001-5760-6351
Brim, Hassan
Chen, Yu
Cortez, Melissa M.
Erdmann, Nathan B.
Flaherman, Valerie
Goepfert, Paul https://orcid.org/0000-0001-8441-5737
Goldman, Jason D. https://orcid.org/0000-0002-3825-6832
Hamburg, Naomi M.
Han, Jenny E. https://orcid.org/0000-0003-1103-3935
Heath, James R.
Jacoby, Vanessa
Jolley, Sarah E.
Kelly, J. Daniel https://orcid.org/0000-0002-7616-0321
Kelly, Sara W. https://orcid.org/0000-0001-8544-4767
Kim, C. https://orcid.org/0000-0002-3881-1592
Krishnan, Jerry A. https://orcid.org/0000-0001-5525-4778
Letts, Rebecca https://orcid.org/0009-0009-4747-7918
Levitan, Emily B. https://orcid.org/0000-0002-5429-3852
Modes, Matthew E.
McComsey, Grace A. https://orcid.org/0000-0003-2690-8888
Metz, Torri D.
Mullington, Janet M. https://orcid.org/0000-0002-9156-9424
Ofotokun, Igho
Okumura, Megumi J.
Paredes, Claudia Castillo
Patterson, Thomas F.
Peluso, Michael J. https://orcid.org/0000-0003-0585-6230
Reece, Rebecca https://orcid.org/0000-0002-3126-5568
Sherif, Zaki A. https://orcid.org/0000-0002-1772-7041
Simhan, Hyagriv N.
Simmons, Christopher
Singh, Upinder
Taylor, Barbara S.
Taylor, Brittany D. https://orcid.org/0009-0009-4037-5708
Trinity, Joel D.
Troxel, Andrea B.
Utz, Paul J. https://orcid.org/0000-0003-1181-1565
Vasey, Andrew J. https://orcid.org/0000-0003-3084-7416
Weinberger, Elisheva
Wiley, Zanthia
Wisnivesky, Juan
Yee, Lynn M.
Horwitz, Leora
Foulkes, Andrea S.
Levy, Bruce D.
,
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (OTA OT2HL161841, OT2HL161847, OT2HL156812, OT2HL162087, and R01 HL162373)
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 8 October 2025
First Online: 17 November 2025
Competing interests
: J.D.G. reports grants from Gilead; and serving as a speaker, consultant or advisory board member for Gilead, Merck, and Ivivyd related to Long COVID, outside the submitted work. M.J.P. has received consulting fees related to Long COVID from Gilead Sciences, AstraZeneca, BioVie, Apellis Pharmaceuticals, and BioNTech, travel support from Invivyd, and research support from Aerium Therapeutics and Shionogi, outside the submitted work. J.W. has received funding from Regeneron for a study assessing the immune response to covid infection and vaccination among immunosuppressed patients and consulted and was an author on a meta-analysis of the impact of vaccination on the prevention of Long COVID for BioNTech. The remaining authors declare no competing interests.
